Wen-Wei Liao1, Xiang-Chao Ling1, Cheng Zhang1, Fu-Rong Liu2, Xiao-Feng Zhu1, Xiao-Shun He1, An-Bin Hu1. 1. Organ Transplantation Center of the First Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation Center), Guangzhou, China. 2. Cardiac Surgery Itensive Care Unit of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Pancreas transplantation, particularly simultaneous pancreas–kidney transplantation, has become a radical treatment for patients with type 1 diabetes mellitus (T1DM), patients with T1DM with end-stage renal disease, and some patients with type 2 diabetes mellitus (T2DM).[1-4] As of 2014, approximately 40,000 cases of pancreas transplantation had been performed worldwide, with an average of 900 cases per year. The recipient and graft survival rates have continually improved, with an overall 5-year survival rate of 90%.[5,6] Considering the substantial number of patients with DM in the general population, the number of transplant cases and the graft survival rate are considerably lower than those for kidney or liver transplantation. Possible reasons for these differences include concerns about higher surgical risk in pancreas transplantation and the availability of the procedure, which is limited to a few domestic and foreign transplant centers. After pancreas transplantation, vascular complications such as thrombosis and hemorrhage are mainly responsible for pancreatic graft failure.[7-9]At most pancreas transplantation centers, the donor pancreas is procured only with the splenic artery and the superior mesenteric artery. The celiac trunk is preserved for the donor liver. Thus, the pancreas transplant must be prepared ex situ before transplantation with a Y-graft between the splenic artery and superior mesenteric artery using the donor’s external, internal, or common iliac artery.4 In China, en bloc removal of the pancreas and liver is a common practice and is followed by ex situ separation of the donor pancreas from the donor liver. The celiac trunk, superior mesenteric artery, and partial abdominal aorta from which these two arteries arise are preserved for the donor pancreas, and the common hepatic artery is preserved for the donor liver. Anastomosis of the proximal hepatic artery to the distal gastroduodenal artery is performed to reconstruct the arterial arch of the pancreatic head. In terms of vein management, the donor’s common iliac vein is anastomosed to the portal vein preserved in the donor pancreas to lengthen the pancreatic vein outflow channel and facilitate surgery in the recipient. These vascular anastomoses and reconstructions not only prolong the duration of pancreas preparation but inevitably increase the incidence of postoperative vascular complications because of the increased number of vascular anastomoses.To reduce the vascular complication rate and improve the comprehensive efficacy of pancreas transplantation, we modified the vascular preparation of the donor pancreas based on the experiences in domestic and international transplantation centers; i.e., no vascular reconstruction was performed. This novel procedure can theoretically reduce the incidence of vascular complications caused by thrombosis, hemorrhage, and prolonged cold ischemia.
Materials and methods
Recipient data
All recipients in this study were diagnosed with DM complicated with renal failure and scheduled to undergo simultaneous pancreas–kidney transplantation. All patients received insulin treatment to control their blood glucose levels and presented with varying degrees of DM-related complications. The detailed patient data are shown in Table 1.
Table 1.
Preoperative characteristics of recipients undergoing simultaneous pancreas–kidney transplantation.
Patient number
Age (years)
Sex
Diabetes type
Major comorbidities
Hemoglobin level (g/L)
Albumin level (g/L)
Blood glucose level (mmol/L)
Creatinine level (µmol/L)
Fasting C-peptide level (mmol/L)
Blood insulin level (mmol/L)
1
60
Male
II
Renal failureRetinopathy
123
38.2
4.4
668
0.399
36.7
2
27
Male
I
Renal failureRetinopathy
83
29.5
9.5
656
0.003
5.50
3
49
Male
II
Renal failure
80
25.4
5.2
1338
4.010
27.94
4
40
Female
I
Renal failure
83
36.0
9.0
302
0.079
3.65
5
44
Male
II
Renal failureRetinopathy
103
32.3
12.4
390
0.758
44.80
6
48
Male
II
Renal failure
115
42.7
7.7
563
0.015
22.10
7
30
Male
I
Renal failure
92
34.9
7.7
583
0.312
5.80
8
48
Male
II
Renal failure
116
38.6
5.1
1180
3.99
26.30
9
41
Female
II
Renal failure
91
35.5
6.2
856
0.513
19.80
10
54
Male
II
Renal failure
105
33.6
7.1
578
0.087
33.60
11
56
Male
II
Renal failureRetinopathy
98
28.4
6.8
680
0.629
28.60
12
47
Male
II
Renal failure
88
37.1
4.7
591
0.037
21.70
Preoperative characteristics of recipients undergoing simultaneous pancreas–kidney transplantation.
Donor data
None of the donors had a history of DM or hyperglycemia before donation. The organ donation procedure was performed in accordance with the “Chinese Guidance of Donation after Cardiac Death.” All donor donations were performed after circulatory death.[10] The organs were procured via the rapid procure approach for abdominal organs (5 minutes after cardiac death). The detailed data of the donors are shown in Table 2.
Table 2.
Characteristics of donors for simultaneous pancreas–kidney transplantation.
Donor No.
Sex
Age (years)
Cause of death
Pathogenic examination
Liver and kidney function
Blood sugar level (mmol/L)
Weight, height, BMI (kg, cm, kg/m2)
Presence of low blood pressure and low blood oxygen
Application of ventilator
1
Male
19
Brain trauma due to car accident
Negative
Normal
5.07
70, 180, 20
None
Yes
2
Male
42
Extremely severe craniocerebral trauma
Negative
normal
5.69
60, 168, 21
None
Yes
3
Male
21
Brain trauma due to car accident
Negative
Normal
6.00
55, 173, 19
None
Yes
4
Male
27
Extremely severe craniocerebral trauma
Negative
Normal
5.34
70, 170, 24
None
Yes
5
Male
8
Ganglion neuroblastoma
Negative
Normal
9.00
28, 120, 19
None
Yes
6
Male
19
Brain injury due to gunshot Cerebral hernia
Positive sputum smear
Normal
15.56
50, 168, 18
None
Yes
7
Male
25
Spontaneous intracerebral hemorrhage
Negative
Normal
5.69
60, 168, 21
Presence of low blood pressure/no hypoxia
Yes
8
Male
22
Severe craniocerebral trauma
Negative
Normal
6.80
66, 174, 22
None
Yes
9
Female
16
Brain trauma due to car accident
Negative
Normal
5.80
40, 150, 17
None
Yes
10
Female
26
CO poisoning
Negative
Normal
5.95
63, 168, 22
None
Yes
11
Male
50
Severe craniocerebral trauma
Negative
Normal
7.62
71, 176, 24
None
Yes
12
Female
25
Brain trauma due to car accident
Negative
Normal
3.89
46, 162, 18
None
Yes
BMI, body mass index; CO, carbon monoxide.
Characteristics of donors for simultaneous pancreas–kidney transplantation.BMI, body mass index; CO, carbon monoxide.
Donor pancreas procure
The en bloc removal technique for multiple abdominal organs was used to procure the donor pancreas. Ex situ separation of the donor pancreas from the donor liver was performed on the organ preparation table. The hepatoduodenal ligament was dissected. The common bile duct was excised close to the duodenum. The portal vein was transected in the middle of the hepatoduodenal ligament. The common hepatic artery and the gastroduodenal artery were transected at a site 0.5 cm from the bifurcation after separation. The bifurcated portion was preserved for the donor liver. The stumps of the preserved common hepatic artery and the gastroduodenal artery in the donor pancreas were marked with 6-0 Prolene sutures. At this point, the pancreas was separated from the liver.
Preparation of donor pancreas
For artery preparation, the patch was preserved simultaneously with the celiac trunk and superior mesenteric artery. Heparinsaline was injected into the superior mesenteric artery, and an overflow sign from the stump of the gastroduodenal artery (which was excised during separation from the liver) indicated that the arterial arch of the pancreatic head was intact. Anastomosis was not required; the stumps of the gastroduodenal artery and common hepatic artery only needed to be ligated. The Carrel patch served as the inflow artery; a Y-graft was not required. For vein preparation, the portal vein was transected in the middle of the hepatoduodenal ligament to ensure a sufficient length of the anastomosis in the recipient, as previously described; lengthening of the portal vein was not required. At this point, pancreas preparation without ex situ blood vessel anastomosis was completed (Figure 1(a) and (b)).
Figure 1.
(a) Diagram and (b) photograph of pancreas preparation.
(a) Diagram and (b) photograph of pancreas preparation.
Surgical procedure in recipients
A para-rectus abdominis incision was made in the right lower abdomen to mobilize the external iliac artery and vein. The prepared donor pancreas was longitudinally placed in the right iliac fossa within the abdominal cavity, with the pancreatic head toward the head side. End-to-side anastomosis of the donor Carrel patch to the recipient’s external iliac artery was performed. The portal vein of the donor pancreas was anastomosed end-to-side to the recipient’s external iliac vein. A lateral incision was made in the side wall of the preserved duodenum in the donor pancreas, and leakage of pancreatic juice was observed. Side-to-side anastomosis of the donor duodenum and the recipient’s jejunum was performed to establish a channel for the pancreatic secretions (Figure 2(a)–(c)).
Figure 2.
Operative photographs of a pancreas transplant.
Operative photographs of a pancreas transplant.
Ethics statement
This study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (No. 2018-0096).
Results
The recipients comprised 12 patients (10 men and 2 women); 3 were primarily diagnosed with T1DM, and 9 were diagnosed with T2DM. Twelve donors were also included in the study. Pancreas preparation without vascular reconstruction was used in all 12 patients undergoing pancreas transplantation. Anastomosis of the donor portal vein and recipient external iliac vein was performed in the recipients; the donor Carrel patch was anastomosed to the external iliac artery of the recipient. The anastomosis procedure went smoothly. When the clamp was removed, the pancreatic blood inflow and outflow appeared normal. All 12 patients returned to consciousness 4 to 6 hours after the end of anesthesia. The patients were weaned from mechanical ventilation 8 to 14 hours after surgery. The patients stayed in the surgical intensive care unit for 2 to 3 days after surgery and were then transferred to the regular ward for routine rehabilitation. Flatus and defecation were reported 5 to 6 days after surgery. The serum C-reactive peptide levels returned to normal limits within 1 to 2 weeks, and the blood glucose and creatinine levels returned to normal limits within 2 to 3 weeks (Figure 3(a)–(c)). The transplanted pancreas functioned well in all recipients, and no vascular complications were reported.
Figure 3.
Early changes in the pancreas and renal function in patients undergoing pancreas transplantation.
Early changes in the pancreas and renal function in patients undergoing pancreas transplantation.
Discussion
Pancreas transplantation is an effective method for the treatment of end-stage DM.[11-13] The difficulty of pancreas transplantation is mainly due to the anatomical and physiological characteristics of the pancreas itself. The pancreatic blood supply and structure are complicated by the multiple blood vessels involved. Furthermore, the pancreatic tissues are fragile, easily damaged, and sensitive to ischemia. Therefore, pancreas procurement and preparation are keys to successful transplantation.A successful pancreas transplantation depends largely on the surgical techniques used.[14,15] Separation of the pancreas from the liver and performance of an isolated transplantation was historically considered impossible because the liver and pancreas share blood vessels.[16] The arterial blood supply of the pancreas mainly comes from three arteries: the superior mesenteric artery, the gastroduodenal artery, and the splenic artery. The pancreatic head is supplied by two arterial arches: (1) the anterior arterial arch, which includes the superior-anterior pancreaticoduodenal artery arising from the gastroduodenal artery and the inferior-anterior pancreaticoduodenal artery arising from the superior mesenteric artery, and (2) the posterior arterial arch, which includes the superior-posterior pancreaticoduodenal artery arising from the gastroduodenal artery and the inferior-posterior pancreaticoduodenal artery arising from the superior mesenteric artery. The two arterial arches supply the pancreatic head, the uncinate process, and the portion of the duodenum around the pancreatic head. The pancreatic body and tail are supplied by the splenic artery and its branches, especially the dorsal pancreatic artery and transverse pancreatic artery. Surgeons historically recommended preservation of the celiac trunk, splenic artery, and superior mesenteric artery for transplantation of the whole pancreas.[17] Separation and isolated transplantation of the liver and pancreas are relatively difficult because both transplants require use of the celiac trunk. In the late 1980s, these procedures became feasible after development of arterial reconstruction techniques.[18,19]In pancreas transplantation, arterial and venous reconstruction increases both the time required for pancreas preparation and the incidence of complications, including postoperative thrombosis, hemorrhage, pancreatic leakage, and intestinal leakage. A prolonged preparation time leads to a prolonged cold ischemia time, which causes corresponding complications such as pancreatic edema and pancreatitis. According to a study by Sutherland et al.,[20] the incidence of surgical complications in pancreatic transplantation ranges from 8% to 45%. A study by Harbell et al.[21] involving 112 patients undergoing pancreas transplantation with vascular reconstruction revealed postoperative thrombosis in 30 (27%) patients, graft loss in 5 patients, and venous thrombosis in 4 patients during the 5-year period following transplantation. Surgical complications often led to removal of the transplanted pancreas.To address these problems, the portal vein was transected in the middle of the hepatoduodenal ligament to ensure a sufficient length for transplantation. Lengthening of the portal vein was not necessary. In addition, heparinsaline was injected into the superior mesenteric artery to test the integrity of the arterial arches of the pancreatic head. An overflow sign from the stump of the gastroduodenal artery indicated that anastomosis of the gastroduodenal artery and common hepatic artery was not required, but the stumps of the gastroduodenal artery and common hepatic artery needed to be ligated. The Carrel patch served as an inflow artery, and a Y-graft was not required.
Conclusions
The modified donor pancreas preparation without vascular anastomosis used in this study can significantly improve surgical efficiency. Theoretically, the omission of vascular anastomosis can greatly reduce the incidence of hemorrhage and thrombosis (no complications were reported in 12 patients in this study), promote patient recovery, and improve the comprehensive efficacy of pancreatic transplantation. However, the limitations of this study included its small sample size and short observation period. Thus, further studies are needed to improve pancreas transplantation.
Abbreviations
DM: diabetes mellitus. T1DM: type 1 diabetes mellitus. T2DM: type 2 diabetes mellitus.
Authors: F L Delmonico; R L Jenkins; H Auchincloss; T J Etienne; P S Russell; A B Monaco; A B Cosimi Journal: Surgery Date: 1989-06 Impact factor: 3.982
Authors: J W Harbell; T Morgan; V A Feldstein; G R Roll; A Posselt; S-M Kang; S Feng; R Hirose; C E Freise; P Stock Journal: Am J Transplant Date: 2017-08-14 Impact factor: 8.086
Authors: D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian Journal: Ann Surg Date: 2001-04 Impact factor: 12.969
Authors: Marie Thuong; Angel Ruiz; Patrick Evrard; Michael Kuiper; Catherine Boffa; Mohammed Z Akhtar; James Neuberger; Rutger Ploeg Journal: Transpl Int Date: 2016-05-04 Impact factor: 3.782
Authors: R Kandaswamy; P G Stock; S K Gustafson; M A Skeans; M A Curry; M A Prentice; A Fox; A K Israni; J J Snyder; B L Kasiske Journal: Am J Transplant Date: 2018-01 Impact factor: 8.086
Authors: Matthias Waldner; Thomas Bächler; Erik Schadde; Marc Schiesser; Franz Immer; Pierre-Alain Clavien; Jens Gunther Brockmann Journal: Transpl Int Date: 2012-10-16 Impact factor: 3.782